Nos publications
Mise à jour août 2024
Pagination
- Page précédente
- Page 10
- Page suivante
Title | Authors | Year Trier par ordre croissant | Journal | Link to Article | Intended Audience | Purpose |
---|---|---|---|---|---|---|
Blood is a politic of place-making: Blackness, queerness and the construction of the donor | Dryden OH | 2022 | Harriet’s Legacies: Race, Historical Memory, and Futures in Canada | View Blood is a politic of place-making: Blackness, queerness and the construction of the donor | Researchers | MSM research |
Automated closed volume reduction process for apheresis stem cell grafts: From development to clinical implementation | Howell A, Letcher B, Murphy K, Elmoazzen H, Petraszko T, Acker JP, Pineault N, Holovati JL | 2022 | Transfusion | View Automated closed volume reduction process for apheresis stem cell grafts: From development to clinical implementation | Researchers | New or improved product or process |
A data-informed system to manage scarce blood product allocation in a randomized controlled trial of convalescent plasma | Li N, Zeller MP, Shih AW, Heddle NM, St. John M, Bégin P, Callum J, Arnold DM, Akbari-Moghaddam M, Down DG, Jamula E, Devine DV, Tinmouth A | 2022 | Transfusion | View A data-informed system to manage scarce blood product allocation in a randomized controlled trial of convalescent plasma | Researchers | Clinical research |
Rapport de surveillance | O'Brien SF | 2022 | Blood.ca website | View Rapport de surveillance | Blood operators | Benchmarking and standard setting |
Current status of rapid bacterial detection methods for platelet components: A 20-year review by the ISBT Transfusion-Transmitted Infectious Diseases Working Party Subgroup on Bacteria | Schmidt M, Ramirez-Arcos S, Stiller L, McDonald C, ISBT Transfusion-Transmitted Infectious Diseases Working Party Subgroup on Bacteria | 2022 | Vox Sang | View Current status of rapid bacterial detection methods for platelet components: A 20-year review by the ISBT Transfusion-Transmitted Infectious Diseases Working Party Subgroup on Bacteria | Researchers | Benchmarking and standard setting |
2021 Chinese consensus on the diagnosis and management of primary immune thrombocytopenia in pregnancy | Zhang X, Chen F, Chen X, Cheng Y, Fang M, Feng J, Fu H, Gao H, Han Y, He A, Hou M, Hu Y, Huang R, Huang W, Jing Z, Kong P, Liang A, Liang M, Liu D, Liu J, Liu L, Liu X, Ma L, Mei H, Ni H, Niu T, Peng J, Qiao J, Ren J, Song Y, Tang LV, Tong T, Wang S, Wang X, Wang Z, Wei H, Wu D, Wu G, Xu C, Xu X, Xu Y, Yang L, Yang R, Yang T, Yin C, Yu L, Zhang G, Zhang L, Zhang L, Zhang X, Zhao W, Zhao Y, Zhou D, Zhou H, Zhou Z, Zhu T, Wang J, Huang X | 2022 | Chin Med J (Engl) | View 2021 Chinese consensus on the diagnosis and management of primary immune thrombocytopenia in pregnancy | Health care providers | Clinical research |
International Forum on the Management of Major Haemorrhage: Summary | Green L, Stanworth S, McQuilten Z, Lin V, Tucker H, Jackson B, Badawi M, Hindawi S, Chaurasia R, Patidar G, Pandey HC, Fasola F, Miyata S, Matsumoto M, Matsushita T, Rahimi-Levene N, Peer V, Pavenski K, Callum J, Thompson T, Murphy M, Staves J, Maegele M, Abeyakoon C, Rushford K, Wood E, Nuñez MA, Mellado S, Saa E, Triyono T, Pratomo B, Apelseth TO, Dunbar N | 2022 | Vox Sang | View International Forum on the Management of Major Haemorrhage: Summary | Health care providers | Benchmarking and standard setting |
Reply to: Concerns about estimating relative risk of death associated with convalescent plasma for COVID-19 | Bégin P, Callum J, Cook R, Jamula E, Liu Y, Finzi A, Arnold DM | 2022 | Nat Med | View Reply to: Concerns about estimating relative risk of death associated with convalescent plasma for COVID-19 | Researchers | Clinical research |
Removing the men who have sex with men blood donation deferral: Informing risk models using Canadian public health surveillance data | Caffrey N, Goldman M, Lewin A, Grégoire Y, Yi QL, O’Brien SF | 2022 | Transfus Clin Biol | View Removing the men who have sex with men blood donation deferral: Informing risk models using Canadian public health surveillance data | Researchers | MSM research |
SARS-CoV-2 seroprevalence among Vancouver public school staff in British Columbia, Canada: a cross-sectional study | Goldfarb DM, Mâsse LC, Watts AW, Hutchison SM, Muttucomaroe L, Bosman ES, Barakauskas VE, Choi A, Dhillon N, Irvine MA, Reicherz F, O’Reilly C, Sediqi S, Xu RY, Razzaghian HR, Sadarangani M, Coombs D, O’Brien SF, Lavoie PM | 2022 | BMJ Open | View SARS-CoV-2 seroprevalence among Vancouver public school staff in British Columbia, Canada: a cross-sectional study | Researchers | Clinical research |
Doxorubicin-Induced Platelet Activation and Clearance Relieved by Salvianolic Acid Compound: Novel Mechanism and Potential Therapy for Chemotherapy-Associated Thrombosis and Thrombocytopenia | Ma W, Rousseau Z, Slavkovic S, Shen C, Yousef GM, Ni H | 2022 | Pharmaceuticals | View Doxorubicin-Induced Platelet Activation and Clearance Relieved by Salvianolic Acid Compound: Novel Mechanism and Potential Therapy for Chemotherapy-Associated Thrombosis and Thrombocytopenia | Researchers | Basic research |
Circulaire d'information utilisation de composants sanguins humains: Plaquettes | Stewart T | 2022 | Blood.ca website | View Circulaire d'information utilisation de composants sanguins humains: Plaquettes | Health care providers | Benchmarking and standard setting |
Circular of information for the use of human blood components: Pathogen Reduced Platelet Concentrates | Stewart T | 2022 | Blood.ca website | View Circular of information for the use of human blood components: Pathogen Reduced Platelet Concentrates | Health care providers | Benchmarking and standard setting |
International Forum on Gender Identification and Blood Collection: Summary | Pandey S, Gorlin JB, Townsend M, Van Buren N, Leung JNS, Lee CK, van den Hurk K, Casamitjana N, Valles R, Alonso E, Miller YM, Richard P, Woimant G, Tiberghien P, Zhiburt E, Butler-Foster T, Goldman M, Nissen-Meyer LSH, Espinosa A, Kamel H, Bravo M, Filho LA, Pecego M, Germain M, Rabusseau I, Shinar E, Raz H, Choudhury N, Bhatnagar N, Hurt K, Lopez M, Reik RA, Nie Y, Hung Y, Pheello L, Dunbar N | 2022 | Vox Sang | View International Forum on Gender Identification and Blood Collection: Summary | Blood operators | Benchmarking and standard setting |
ResearchUnit: Whole blood: longer holding times before leukoreduction may be a safe to explore option | Chen ZY | 2022 | Blood.ca website | View ResearchUnit: Whole blood: longer holding times before leukoreduction may be a safe to explore option | Regulators | New or improved product or process |
Spotlight on animal models of acute traumatic coagulopathy: An update | Ask A, Eltringham-Smith L, Bhakta V, Donkor DA, Pryzdial ELG, Sheffield WP | 2022 | Transfus Apher Sci | View Spotlight on animal models of acute traumatic coagulopathy: An update | Researchers | Basic research |
A naturally present autoantibody to senescent red blood cells? | Badior KE, Bloch EM, Branch DR | 2022 | Transfusion | View A naturally present autoantibody to senescent red blood cells? | Researchers | Benchmarking and standard setting |
Opposing roles of CLK SR kinases in controlling HIV-1 gene expression and latency | Dahal S, Clayton K, Been T, Fernet-Brochu R, Ocando AV, Balachandran A, Poirier M, Maldonado RK, Shkreta L, Boligan KF, Guvenc F, Rahman F, Branch D, Bell B, Chabot B, Gray-Owen SD, Parent LJ, Cochrane A | 2022 | Retrovirology | View Opposing roles of CLK SR kinases in controlling HIV-1 gene expression and latency | Researchers | Basic research |
A data-driven approach to determine daily platelet order quantities at hospitals | Mirjalili M, Abouee-Mehrizi H, Barty R, Heddle NM, Sarhangian V | 2022 | Transfusion | View A data-driven approach to determine daily platelet order quantities at hospitals | Researchers | New or improved product or process |
Chapitre 5. Concentrés pour les troubles de l’hémostase et l’angiœdème héréditaire | Poon MC, Goodyear D, Rydz N, Lee A | 2022 | Guide de la pratique transfusionnelle | View Chapitre 5. Concentrés pour les troubles de l’hémostase et l’angiœdème héréditaire | Health care providers | Benchmarking and standard setting |
Resistance of SARS-CoV-2 beta and gamma variants to plasma collected from Canadian blood donors during the spring of 2020 | Drews SJ, Abe KT, Hu Q, Samson R, Gingras A-C, Colwill K, Rathod B, Wang J, Fazel-Zarandi M, Yi Q-L, Robinson A, Wood H, Tuite A, Fisman D, Evans DH, Lin Y-CJ, O'Brien SF | 2022 | Transfusion | View Resistance of SARS-CoV-2 beta and gamma variants to plasma collected from Canadian blood donors during the spring of 2020 | Researchers | Clinical research |
Epidemiology of Hospitalized Patients with Babesiosis, United States, 2010-2016 | Bloch EM, Day JR, Krause PJ, Kjemtrup A, O'Brien SF, Tobian AAR, Goel R | 2022 | Emerg Infect Dis | View Epidemiology of Hospitalized Patients with Babesiosis, United States, 2010-2016 | Health care providers | Clinical research |
Bacterial contamination of blood components | Bloch EM, Benjamin RJ, Ramirez-Arcos S | 2022 | Rossi's Principles of Transfusion Medicine | View Bacterial contamination of blood components | Health care providers | Benchmarking and standard setting |
Closed system processing variables affect post-thaw quality characteristics of cryopreserved red cell concentrates | Howell A, Turner TR, Hansen A, Lautner LJ, Yi Q, Acker JP | 2022 | Transfusion | View Closed system processing variables affect post-thaw quality characteristics of cryopreserved red cell concentrates | Researchers | Basic research |
Development and validation of a sensitive flow cytometric method for determining CECs in RBC products | Li W, Acker JP | 2022 | Clin Chim Acta | View Development and validation of a sensitive flow cytometric method for determining CECs in RBC products | Researchers | New or improved product or process |
Canadian blood suppliers: An expanding role in public health surveillance? | O'Brien SF, Drews SJ, Lewin A, Osiowy C, Drebot MA, Renaud C | 2022 | Can Commun Dis Rep | View Canadian blood suppliers: An expanding role in public health surveillance? | Health care providers | New or improved product or process |
Minimal impact of anticoagulant on in vitro whole blood quality throughout a 35-day cold-storage regardless of leukoreduction timing | Schubert P, Culibrk B, Bhakta V, Closas T, Sheffield WP, Devine DV, McTaggart K | 2022 | Transfusion | View Minimal impact of anticoagulant on in vitro whole blood quality throughout a 35-day cold-storage regardless of leukoreduction timing | Researchers | Basic research |
Novel contact–kinin inhibitor sylvestin targets thromboinflammation and ameliorates ischemic stroke | Zhang Z, Shen C, Fang M, Han Y, Long C, Liu W, Yang M, Liu M, Zhang D, Cao Q, Chen X, Fang Y, Lu Q, Hou Z, Li Y, Liu Z, Lei X, Ni H, Lai R | 2022 | Cell Mol Life Sci | View Novel contact–kinin inhibitor sylvestin targets thromboinflammation and ameliorates ischemic stroke | Researchers | Basic research |
Bacterial contamination of platelet components | Ramirez-Arcos S, McDonald C, ISBT Transfusion-Transmitted Infectious Disease Bacterial Working Party Bacterial Subgroup | 2022 | Ann Blood | View Bacterial contamination of platelet components | Blood operators | Benchmarking and standard setting |
Behaviour based screening questions and potential donation loss using the “for the assessment of individualised risk” screening criteria: A Canadian perspective | Caffrey N, Goldman M, Lewin A, Osmond L, O'Brien SF | 2022 | Transfus Med | View Behaviour based screening questions and potential donation loss using the “for the assessment of individualised risk” screening criteria: A Canadian perspective | Researchers | MSM research |
Screening for high-risk sexual behavior in Canada | Goldman M, Caffrey N, O'Brien SF | 2022 | Transfusion | View Screening for high-risk sexual behavior in Canada | Blood operators | Clinical research |
FAQ: Whole blood, leukocytes reduced (LrWB) at Canadian Blood Services | Mack J | 2022 | Blood.ca website | View FAQ: Whole blood, leukocytes reduced (LrWB) at Canadian Blood Services | Health care providers | New or improved product or process |
Circulaire d'information utilisation de composants sanguins humains: Cellules progénitrices hématopiétiques de sang de cordon omilical | Stewart T | 2022 | Blood.ca website | View Circulaire d'information utilisation de composants sanguins humains: Cellules progénitrices hématopiétiques de sang de cordon omilical | Health care providers | Benchmarking and standard setting |
Convalescent plasma for adults with acute COVID-19 respiratory illness (CONCOR-1): Study protocol for an international, multicenter, randomized open-label trial | Bégin P, Callum J, Heddle N, Cook R, Zeller MP, Tinmouth A, Fergusson D, Cushing MM, Glesby MJ, Chassé M, Devine DV, Robitaille N, Bazin R, Shehata N, Finzi A, McGeer A, Scales D, Schwartz L, Turgeon AF, Zarychanski R, Daneman N, Carl R, Amorim L, Gabe C, Ellis M, Jamula E, Carruthers J, Duncan J, Lucier K, Armali C, Kron A, Modi D, Auclair M-C, Avram M, Arnold DM | 2021 | Trials | View Convalescent plasma for adults with acute COVID-19 respiratory illness (CONCOR-1): Study protocol for an international, multicenter, randomized open-label trial | Researchers | Clinical research |
In Vitro Characterization and Metabolomic Analysis of Cold-Stored Platelets | Zhao HW, Serrano K, Stefanoni D, D’Alessandro A, Devine DV | 2021 | J Proteome Res | View In Vitro Characterization and Metabolomic Analysis of Cold-Stored Platelets | Researchers | Basic research |
Pathogen reduction of whole blood: Supplementing fibrinogen partly corrects clot formation in a massive transfusion model | Arbaeen AF, Schubert P, Sheffield WP, Devine DV | 2021 | Transfusion | View Pathogen reduction of whole blood: Supplementing fibrinogen partly corrects clot formation in a massive transfusion model | Researchers | New or improved product or process |
ResearchUnit: Perioperative treatment for patients with immune thrombocytopenia: Eltrombopag vs IVIG | Arnold DM | 2021 | Blood.ca website | View ResearchUnit: Perioperative treatment for patients with immune thrombocytopenia: Eltrombopag vs IVIG | Health care providers | Clinical research |
Heparin-Induced Thrombocytopenia and Vaccine-Induced Immune Thrombotic Thrombocytopenia Antibodies: Fraternal-Not Identical-Twins | Warkentin TE | 2021 | Thromb Haemost | View Heparin-Induced Thrombocytopenia and Vaccine-Induced Immune Thrombotic Thrombocytopenia Antibodies: Fraternal-Not Identical-Twins | Researchers | Clinical research |
Vaccine-induced immune thrombotic thrombocytopenia presenting with normal platelet count | Page D, Zhu N, Sawler D, Sun HW, Turley E, Pai M, Wu C | 2021 | Res Pract Thromb Haemost | View Vaccine-induced immune thrombotic thrombocytopenia presenting with normal platelet count | Researchers | Clinical research |
Teaching bone marrow procedures at pelvic and sternal sites: a high fidelity anatomy simulation | Heather Vander M, Laureano M, Hu G, Lim W, Ross C, Wainman B, Zeller MP | 2021 | Can Med Educ J | View Teaching bone marrow procedures at pelvic and sternal sites: a high fidelity anatomy simulation | Health care providers | Benchmarking and standard setting |
Chaptire 16: Don autologue préopératoire | Foster T, Yan M | 2021 | Guide de la pratique transfusionnelle | View Chaptire 16: Don autologue préopératoire | Health care providers | Benchmarking and standard setting |
External qualification of the Web-Accessible Population Pharmacokinetic Service-Hemophilia (WAPPS-Hemo) models for octocog alfa using real patient data | Chelle P, Hajducek D, Mahdi M, Young S, Iorio A, Silvertown J, Edginton A | 2021 | Res Pract Thromb Haemost | View External qualification of the Web-Accessible Population Pharmacokinetic Service-Hemophilia (WAPPS-Hemo) models for octocog alfa using real patient data | Researchers | New or improved product or process |
Anti-inflammatory activity of CD44 antibodies in murine immune thrombocytopenia is mediated by Fc? receptor inhibition | Norris PAA, Kaur G, Khan R, Zhu G, Ni H, Lazarus AH | 2021 | Blood | View Anti-inflammatory activity of CD44 antibodies in murine immune thrombocytopenia is mediated by Fc? receptor inhibition | Researchers | Basic research |
Circular of information for the use of human blood components: Hematopoietic Progenitor Cells (HPC), Cord Blood | Jenkins C | 2021 | Blood.ca website | Health care providers | Benchmarking and standard setting | |
FAQ: Canadian Blood Services Platelet Bacterial Testing | Khandelwal A, Ramirez-Arcos S, Bigham M | 2021 | Blood.ca website | View FAQ: Canadian Blood Services Platelet Bacterial Testing | Health care providers | Other |
Platelet-activating immune complexes identified in critically ill COVID-19 patients suspected of heparin-induced thrombocytopenia | Nazy I, Jevtic SD, Moore JC, Huynh A, Smith JW, Kelton JG, Arnold DM | 2021 | J Thromb Haemost | View Platelet-activating immune complexes identified in critically ill COVID-19 patients suspected of heparin-induced thrombocytopenia | Health care providers | Clinical research |
Selection and in vitro and in vivo characterization of a Kunitz protease inhibitor domain of protease nexin 2 variant that inhibits factor XIa without inhibiting plasmin | Eltringham-Smith LJ, Bhakta V, Sheffield WP | 2021 | J Biotechnol | View Selection and in vitro and in vivo characterization of a Kunitz protease inhibitor domain of protease nexin 2 variant that inhibits factor XIa without inhibiting plasmin | Researchers | Basic research |
Five novel FY null alleles associated with typing discrepancies | Vege S, Floch A, Lomas-Frances C, Clarke G, Westhoff CM | 2021 | Transfusion | View Five novel FY null alleles associated with typing discrepancies | Researchers | Benchmarking and standard setting |
Background incidence rates of hospitalisations and emergency department visits for thromboembolic and coagulation disorders in Ontario, Canada for COVID-19 vaccine safety assessment: a population-based retrospective observational study | Nasreen S, Calzavara AJ, Sundaram ME, MacDonald SE, Righolt CH, Pai M, Field TS, Zhou LW, Wilson SE, Kwong JC | 2021 | BMJ Open | View Background incidence rates of hospitalisations and emergency department visits for thromboembolic and coagulation disorders in Ontario, Canada for COVID-19 vaccine safety assessment: a population-based retrospective observational study | Researchers | Clinical research |
Plateletworks® as a Point-of-Care Test for ASA Non-Sensitivity | Khan H, Jain S, Gallant RC, Syed MH, Zamzam A, Al-Omran M, Rand ML, Ni H, Abdin R, Qadura M | 2021 | J Pers Med | View Plateletworks® as a Point-of-Care Test for ASA Non-Sensitivity | Researchers | New or improved product or process |